Pirquinozol
From Self-sufficiency
| File:Pirquinozol.svg | |
| Systematic (IUPAC) name | |
|---|---|
|
2-(hydroxymethyl)pyrazolo[1,5-c]quinazolin-5(6H)-one | |
| Clinical data | |
| Routes of administration | Oral |
| Legal status | |
| Legal status |
|
| Identifiers | |
| CAS Number | 65950-99-4 |
| ATC code | none |
| PubChem | CID 47783 |
| ChemSpider | 11317704 |
| Chemical data | |
| Formula | C11H9N3O2 |
| Molar mass | 215.21 g/mol[[Script error: No such module "String".]] |
| Script error: No such module "collapsible list". | |
Pirquinozol (SQ-13,847) is a drug which was investigated as an antiallergen and antiasthmatic agent in the early 1980s but was never marketed.[1][2][3] Notably, pirquinozol is not an antihistamine, though it does block the release of histamine evoked by allergens, and it does not bind to β-adrenergic receptors either.[1]
References
Cite error: Invalid <references> tag;
parameter "group" is allowed only.
<references />, or <references group="..." />
 |
This pharmacology-related article is a stub. You can help ssf by expanding it. |
Categories:
- Pages with script errors
- Pages with broken file links
- Infobox drug tracked parameters
- Articles without EBI source
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs not assigned an ATC code
- Articles containing unverified chemical infoboxes
- Antiasthmatic drugs
- Lactams
- Pyrazoloquinazolines
- Alcohols
- Ureas
- Pharmacology stubs
- 2Fix
